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1. Introduction 
The Mediterranean variety of genetically inherited 
G6PD deficiency is a convenient model system for 
investigations on the mechanisms of oxidative hemol- 
ysis. In fact: 
(9 
(ii) 
This enzyme disorder is characterized by a partic- 
ularly severe deficiency of catalytic activity, being 
9.1% of the G6PD activity found in erythro- 
cytes from normal subjects [ 11; 
It is associated, although in a characteristically 
non-constant way, with episodes of acute intra- 
vascular hemolysis which are triggered by exoge- 
nous agents such as fava beans and (or) drugs 
resulting in a severe oxidative challenge to the 
affected erythrocytes [2,3]. 
Peroxidation of membrane lipids has long been 
considered as an obligatory step of oxidative hemolysis 
[4]. A preliminary study on the structure of membrane 
lipid components failed to show significant differences 
among erythrocytes from: (a) normal subjects; (b) 
healthy G6PD-deficient subjects; (c) favic patients 
after hemolytic crisis, excepting for a distinctive con- 
tent of palmitic acid [ 51. This is an investigation 
exploring, on a comparative basis between control,and 
G6PDdeficient erythrocytes, the dynamic changes in 
these lipid components which underlie the oxidative 
hemolysis. 
Abbreviations: C6PD, glucose 6-phosphate dehydrogenase; 
SOD, superoxide dismutase; HMS activity, hexose monophos. 
phate shunt activity; PBS, phosphate-buffered saline (pH 7.2) 
[ 201; MDA, malonyldialdehyde; GSH, reduced glutathione; 
DDC, diethyldithiocarbamate 
ElsevierfNorth-Hold Biomedical Press 
2. Materials and methods 
2.1. Blood samples and enzyme assays 
Blood samples from normal male subjects and 
G6PDdeficient males of Sardinian ancestry were 
drawn and processed as in [ I], in order to remove 
leukocytesand platelets completely from erythrocytes 
[ 61. Assays of G6PD activity in hemolysates were done 
as in [ 11. Homogeneous superoxide dismutase (SOD) 
purified from human erythrocytes was a kind gift by 
Professor G. Rotilio. Entrapment of SOD within nor- 
mal and G6PDdeficient erythrocytes was performed 
as in [ 71. Hexose monophosphate shunt (HMS) activity 
of intact erythrocytes was estimated as in [7]. 
2.2. Incubationsof erythrocytes with the H202-NaN3 
system 
These were performed essentially as in [ 81, with 
some modifications. Briefly, mixtures (3 .O ml) con- 
taining isosmotic PBS, erythrocytes at a final hema- 
tocrit of 2 S%, 5 mM glucose, 10 mM NaN3 and HzOz 
at varying concentrations as indicated, were incubated 
for 2 h at 37°C under H,O-saturated oxygen with 
constant stirring. In few experiments the supply of 
HzOz was made according to the vapour-diffusion 
technique as in [ 81, which allowed to reach final Hz02 
concentrations of 44 mM. Aliquots were removed 
and submitted to estimation of malonyldialdehyde 
(MDA) as in [ 81, of the extent of hemolysis by record- 
ing the absorbance at 577 nm and to lipid analyses. 
23. Analysis of lipid components 
This was done as in 151 using the.standards reported. 
Besides to these, 3/3-hydroxy-S-cY-hydroperoxy-A6- 
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cholestene (kindly provided by Professor R. Strom) 
was also used as a standard for gas-liquid chromato- 
graphic analysis of cholesterol. In this procedure [9], 
the two compounds showed sharply different retention 
times. 
3. Results 
3.1. Effects of the Hz02-NaN3 system on the HMS 
activity 
Table 1 shows that the HMS activity of normal 
erythrocytes is enhanced significintly over the situa- 
tion of resting state by the oxidative stress used in this 
study. The extent of such stimulation depends pri- 
marily on the actual concentrations of Hz02. In the 
G6PDdeficient erythrocytes, whose HMS activity in 
resting conditions is lower than in the normal cells, 
the Hz02-NaN3 system fails to stimulate the oxidative 
pathway. This differential response of the HMS activ- 
ity of the normal vs the G6PD-deficient erythrocytes 
to an oxidative stress can be explained on the basis of 
extensive cellular reoxidation of both GSH and 
NADPH [lo,1 11. 
3 2. Dynamic changes in membrane lipids 
Repeated experiments indicated that most mem- 
brane lipid components are unaffected by the H202- 
NaN3 system, both in the normal and in the G6PD- 
deficient erythrocytes. Specifically, cholesterol, total 
phospholipids, phosphatidylcholines, sphingomyelins, 
phosphatidylserines and the major fatty acids (with 
the exception of arachidonic acid) remain at their 
starting levels [5] over the range of HzOz concentra- 
tionsused. On the contrary, the oxidative system used 
in this study produces a remarkable decrease of phos- 
1 I I 
2.5 5.0 7.5 10 
H2o2 CmM > 
Fig.1. Effect of the H,O,-NaN, system on the levels of 
phosphatidylethanolamines: (0) normal erythrocytes; (0) 
erythrocytes from a G6PDdetkient subject. Experimental 
details in section 2. 
phatidylethanolamines (fig.1) as well as of arachidonic 
acid (fig.2). Both variations are similar in extent in 
the normal and in the G6PD-deficient erythrocytes. 
3.3. Lipid peroxidation and hemolysis 
Fig.3, referring to the same experiment illustrated 
by fig.l,2, shows the effect of the H202-NaN3 sys- 
tem in terms of malonyldialdehyde (MDA) formation 
and of hemolysis. Several such experiments indicated 
that lipid peroxidation occurs already at those HzOz 
concentrations which still elicit only negligible hemo- 
lysis. Since MDA formation is related, also from a 
quantitative standpoint, to the fall in arachidonic acid 
and it precedes the hemolysis temporally [8], the 
decrease in lipid components shown in fig.l,2 can be 
regarded as being a pre-hemolytic event. On the other 
hand,a close correlation had been established between 
depletion of membrane phosphatidylethanolamines 
and Hz02-induced hemolysis of rat erythrocytes [4]. 
Table 1 
Effect of various oxidative stresses on the HMS activity of normal and G6PDdeficient erythrocytesa 
Subjects G6PD activity 
W/g Hb)b 
HMS activity 
(nmol “‘CO,. ml erythrocytes-* . h-’ at 37”C)c 
_ MBd NaN, NaN, (10 mM) + NaN, (10 mM) + 
(100 PM) (10 mM) H,O, (1 mM) H,O, (5 mM) 
Normal 4.1 32 1611 102 302 560 
G6PDdeficient 3.6 x 1O-3 14 22 17 12 11 
a Incubation mixtures were as in section 2, excepting for the components outlined and for presence of 
[‘4C]gkcose [7]; b assayed according to [ 11; ‘assayed according to (71; d methylene blue 
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Fig.2. Effect of the H,O,-NaN, system on the levels of 
arachidonic acid: (0) normal erythrocytes; (0) erythrocytes 
from a G6PDdeficient subject. Experimental details in sec- 
tion 2. Arachidonic acid was quantitated by using as internal 
standard heptadecanoic acid which was added to the lipid 
extracts. 
Inspection of fig.3 shows the absence of significant 
differences between normal and G6PD-deficient eryth- 
rocytes in respect to the extent and the dependence 
on HzOz concentrations of both MDA formation and 
hemolysis .
The patterns of oxidative hemolysis were also 
investigated in normal vs G6PD-deficient erythrocytes 
after: 
(i) Entrapment in both types of cells of homogenous 
human superoxide dismutase (SOD); 
(ii) Inhibition of endogenous SOD with diethyldithio- 
carbamate (DDC). 
Procedure (i) did not modify at alI the various events 
under study, i.e ., dynamic changes in membrane lipids, 
MDA formation and hemolysis, even at SOD levels as 
high as nearly 20-fold those assayed in the native 
erythrocytes. However, DDC (ii) was found to modify 
considerably the patterns of oxidative hemolysis 
afforded by the Hz02--NaNa system (fig.4): thus, all 
polyunsaturated fatty acids, besides to arachidonic 
Fig.4. Combined effects of DDC and of the H,O,-NaN, sys- 
tem on the levels of the major polyunsaturated fatty acids 
and on hemolysis: (A) normal erythrocytes; (B) erythrocytes 
from a G6PDdeticient subject; (0) oleic acid; (a) linoleic 
acid; (0) arachidonic acid; (m) hemolysis. Fatty acids were 
quantitated by using heptadecanoic acid as internal standard. 
Experimental details in section 2. DDC was used at a final 
concentration of 10 mM. 
Fig.3. Effect of the H,O,-NaN, system on MDA formation 
and hemolysis: (A) normal erythrocytes; (B) erythrocytes 
from a G6PDdeticient subjects; (0) MDA formation; (D) 
hemolysis. Experimental details in section 2. 
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acid, were destroyed by the oxidative stress, MDA 
production was negligible, in agreement with [ 121 
(not shown) and the extent of hemolysis was largely 
increased over that observed in the absence of DDC. 
In spite of these marked modifications in the bio- 
chemical features of oxidative hemolysis, DDC failed 
to reveal significant differences between normal and 
G6PD-deficient erythrocytes. 
4. Discussion 
The involvement of both HzOz and 0; in the 
mechanism of oxidative hemolysis [ 13,141 prompted 
us to use an experimental system whereby these 
2 oxygen derivatives interact with each other leading 
to erythrocyte destruction. The role of NaNs in this 
system is 2-fold: 
6) 
(ii) 
It acts as a powerful inhibitor of endogenous 
catalase [8], thus reinforcing the effects of added 
HzOz; 
It determines the nucleophilic displacement of 
0; from HbOa [ 151, thereby accounting for the 
concomitant formation of methemoglobin that 
occurs in these conditions. 
The latter can be reduced back to Hb in the presence 
of glucose and Hb02 is reconstituted as a source of 
0;. Use of varying concentrations of HzOz confers 
flexibility to the system the effects of which can there- 
fore be explored on a dose-dependent basis. 
An obvious disadvantage of this oxidative system is 
its remarkable strength which might be expected to 
produce inactivation of specific enzyme proteins. That 
however this is not the case of G6PD and of the overall 
HMS activity is shown by the considerable stimulation 
of the oxidative pathway produced by the HzOz- 
NaNs system in the normal erythrocytes (table 1). 
Such effect rules out also specific inactivations of glu- 
tathione reductase and glutathione peroxidase since 
both enzymes are sequentially involved together with 
the HMS in detoxifying the erythrocyte from H*O,,. 
A sharply distinctive effect on the HMS activity of 
normal vs G6PD-deficient erythrocytes has been I 
observed also with the toxic compounds of fava beans, 
divicine and isouramil [ 161, as well as with a number 
of oxidative drugs entailing a hemolytic risk in the 
G6PD-deficient subjects [ 171. The reason for this dif- 
ferent behaviour is the rate-limiting role that G6PD 
itself playsin the overall pathway of glucose oxidation 
within the deficient but not in the normal cells, when 
these are challenged with an oxidative stress resulting 
in re-oxidation of NADPH [ 7,181. It is the acute failure 
to counteract the cellular effects of an oxidant injury, 
i.e ., oxidative draining of both GSH and NADPH, that 
is commonly thought to cause irreversible damage of 
G6PD-deficient erythrocytes and to precipitate the 
hemolytic crisis. However, this view can hardly be 
reconciled with the closely related features of ‘in vitro’ 
oxidative hemolysis shown in a wide range of experi- 
mental conditions by 2 types of erythrocytes whose 
G6PD activities differ by lOOO-fold from each other. 
Therefore, these findings seem to indicate that an 
oxidative stress alone such as that used here could not 
be sufficient to determine the acute hemolysis of the 
G6PD-deficient subjects and that additional, probably 
extra-erythrocytic factors, may be involved in the 
mechanism of erythrocyte disruption. This view is 
consistent with the well-known variability of the 
hemolytic episodes among G6PDdeficient subjects 
still within homogeneous genetic groups or even 
throughou{ the life of single affected individuals 
[2,3,191. 
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